In most cases, women will only use this drug during pregnancy if the potential benefits are much greater than...
Tag Archive for: HUMIRA
Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) reported top-line results from a phase 3 trial involving their experimental drug sarilumab earlier...
AbbVie Receives Orphan Drug Designation for HUMIRA® (adalimumab) from the U.S. Food and Drug Administration for the Investigational Treatment...
“I WILL NOT HIDE” Hidradenitis suppurativa (HS) Patient Stories Book Series
The “I WILL NOT HIDE” Hidradenitis Suppurativa book series is now available. These patient stories are told in a vivid and personal narrative by HS patients themselves.
HSAWARENESS EMAIL UPDATES
The Latest PUBMED Medical ResearchView All HS Research
- A note on improvement in Dermatology Life Quality Index (DLQI) among patients with hidradenitis suppurativa treated with adalimumab April 19, 2018
- A Core Domain Set For Hidradenitis Suppurativa Trial Outcomes: An International Delphi Process April 14, 2018
- Prevalence Estimates For Hidradenitis Suppurativa Among Children and Adolescents in the United States: a gender and age adjusted population analysis April 13, 2018
- Efficacy and tolerability of a lotion containing triethyl citrate, ethyl linoleate, and GT peptide-10 in the adjuvant treatment of hidradenitis suppurativa: Real-life data April 11, 2018
- Association of Hidradenitis Suppurativa With T Helper 1/T Helper 17 Phenotypes: A Semantic Map Analysis April 4, 2018